The relationship between exercise test variables and other measures of functional impairment in fibrosing alveolitis associated with systemic sclerosis Source: Eur Respir J 2004; 24: Suppl. 48, 254s Year: 2004
Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002
Limiting factors at maximal exercise in sarcoidosis and idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing Year: 2011
Survival and prognostic factors in progressive systemic sclerosis with lung involvement Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009
Histology is not a prognostic indicator in patients with interstitial pneumonias associated with systemic sclerosis Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001
Exhaled 8-isoprostane as a noninvasive marker of oxidative stress in patients with cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001
Pulmonary involvement and exercise limitation in patients with systemic sclerosis Source: Eur Respir J 2004; 24: Suppl. 48, 53s Year: 2004
Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005
Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020
The natural course of systemic sclerosis patients with interstitial lung involvement Source: Eur Respir J 2005; 26: Suppl. 49, 336s Year: 2005
Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013
Acute systemic inflammatory response after peak and constant-work-rate exercise test in hospitalised and stable COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004
Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017 Year: 2018
Nitrogen multiple breath washout indices as potentially prognostic markers in idiopathic pulmonary fibrosis Source: International Congress 2017 – Lung function testing Year: 2017
Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis Source: Eur Respir J 2016; 48: 1658-1667 Year: 2016
Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004
The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019